Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 1
2010 2
2011 1
2012 1
2014 1
2015 1
2017 1
2018 4
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Porocarcinoma: clinical evolution.
Vaz Salgado MA, García CG, Lopez Martin JA, Guerra E, Benito A, Sepulveda JM, Carrato A. Vaz Salgado MA, et al. Among authors: lopez martin ja. Dermatol Surg. 2010 Feb;36(2):264-7. doi: 10.1111/j.1524-4725.2009.01412.x. Dermatol Surg. 2010. PMID: 20402957 No abstract available.
Multidisciplinary management of soft tissue sarcomas.
Luis ÁM, Aguilar DP, Martín JA. Luis ÁM, et al. Among authors: martin ja. Clin Transl Oncol. 2010 Aug;12(8):543-53. doi: 10.1007/s12094-010-0552-2. Clin Transl Oncol. 2010. PMID: 20709652 Review.
Advances in cutaneous melanoma.
Espinosa E, Berrocal A, López Martín JA, González Cao M, Cerezuela P, Mayordomo JI, Martín Algarra S; Grupo Español de Melanoma (GEM). Espinosa E, et al. Among authors: lopez martin ja. Clin Transl Oncol. 2012 May;14(5):325-32. doi: 10.1007/s12094-012-0804-4. Clin Transl Oncol. 2012. PMID: 22551537 Review.
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
Martin-Broto J, Redondo A, Moura DS, Valverde C, Morales JM, Lopez-Pousa A, Martinez-Trufero J, Gutierrez A, Díaz-Beveridge R, Luna P, Martinez-Marin V, Marcilla D, Arribas I, Ledesma P, Lopez-Martin JA, Di Lernia D, Zamora J, Hindi N. Martin-Broto J, et al. Among authors: lopez martin ja. Nat Commun. 2022 Oct 21;13(1):6278. doi: 10.1038/s41467-022-33975-6. Nat Commun. 2022. PMID: 36271011 Free PMC article. Clinical Trial.
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
Aguareles J, Fernández PV, Carralón-González MM, Izquierdo CF, Martí-Ballesteros EM, Fernández VP, Sotres-Fernandez G, García-Delangue T, LaPetra RGV, Sánchez-Manzano MD, Gutiérrez C, García-Coca M, Carnevali-Ruiz D, Barrena-Puertas R, Luque-Pinilla JM, Lloris R, Luepke-Estefan XE, López-Martín JA, Jimeno JM, Guisado-Vasco P. Aguareles J, et al. Among authors: lopez martin ja. Int J Infect Dis. 2023 Oct;135:12-17. doi: 10.1016/j.ijid.2023.07.011. Epub 2023 Jul 21. Int J Infect Dis. 2023. PMID: 37481109 Free article.
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Gonzalez-Cao M, Mayo de Las Casas C, Oramas J, Berciano-Guerrero MA, de la Cruz L, Cerezuela P, Arance A, Muñoz-Couselo E, Espinosa E, Puertolas T, Diaz Beveridge R, Ochenduszko S, Villanueva MJ, Basterretxea L, Bellido L, Rodriguez D, Campos B, Montagut C, Drozdowskyj A, Molina MA, Lopez-Martin JA, Berrocal A. Gonzalez-Cao M, et al. Among authors: lopez martin ja. Nat Commun. 2021 Dec 1;12(1):7008. doi: 10.1038/s41467-021-26572-6. Nat Commun. 2021. PMID: 34853302 Free PMC article. Clinical Trial.
3D bioprinted functional skeletal muscle models have potential applications for studies of muscle wasting in cancer cachexia.
García-Lizarribar A, Villasante A, Lopez-Martin JA, Flandez M, Soler-Vázquez MC, Serra D, Herrero L, Sagrera A, Efeyan A, Samitier J. García-Lizarribar A, et al. Among authors: lopez martin ja. Biomater Adv. 2023 Jul;150:213426. doi: 10.1016/j.bioadv.2023.213426. Epub 2023 Apr 19. Biomater Adv. 2023. PMID: 37104961 Free article.
Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.
Cala MP, Agulló-Ortuño MT, Prieto-García E, González-Riano C, Parrilla-Rubio L, Barbas C, Díaz-García CV, García A, Pernaut C, Adeva J, Riesco MC, Rupérez FJ, Lopez-Martin JA. Cala MP, et al. Among authors: lopez martin ja. J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):348-357. doi: 10.1002/jcsm.12270. Epub 2018 Feb 20. J Cachexia Sarcopenia Muscle. 2018. PMID: 29464940 Free PMC article.
Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.
Berrocal A, Arance A, Lopez Martin JA, Soriano V, Muñoz E, Alonso L, Espinosa E, Lopez Criado P, Valdivia J, Martin Algarra S; Spanish Melanoma Group. Berrocal A, et al. Among authors: lopez martin ja. Melanoma Res. 2014 Dec;24(6):577-83. doi: 10.1097/CMR.0000000000000108. Melanoma Res. 2014. PMID: 25046550 Free PMC article.
In vitro radiosensitisation by trabectedin in human cancer cell lines.
Romero J, Zapata I, Córdoba S, Jimeno JM, López-Martín JA, Tercero JC, De La Torre A, Vargas JA, Molerón R, Sánchez-Prieto R. Romero J, et al. Among authors: lopez martin ja. Eur J Cancer. 2008 Aug;44(12):1726-33. doi: 10.1016/j.ejca.2008.04.013. Epub 2008 May 22. Eur J Cancer. 2008. PMID: 18501589
18 results